-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TbQ6cSOc8oPDfgW76C+zRnuf1eIqLXsjZrCd+ijN2q/ZqOxuOClRchiPJ0vDfrjq VluNEsfkNx4KnpDBKcC9mA== /in/edgar/work/20000801/0000950134-00-006138/0000950134-00-006138.txt : 20000921 0000950134-00-006138.hdr.sgml : 20000921 ACCESSION NUMBER: 0000950134-00-006138 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20000801 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SAFEGUARD HEALTH ENTERPRISES INC CENTRAL INDEX KEY: 0000727303 STANDARD INDUSTRIAL CLASSIFICATION: [6324 ] IRS NUMBER: 521528581 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-35501 FILM NUMBER: 683732 BUSINESS ADDRESS: STREET 1: 95 ENTERPRISE T CITY: ALISO VIEJO STATE: CA ZIP: 92656-2601 BUSINESS PHONE: 9494254110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ANDERSON JACK R CENTRAL INDEX KEY: 0000903766 STANDARD INDUSTRIAL CLASSIFICATION: [0000 ] STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 16475 DALLAS PARKWAY STE 735 STREET 2: CALVER CORP CITY: DALLAS STATE: TX ZIP: 75248 BUSINESS PHONE: 9722487350 MAIL ADDRESS: STREET 1: 14755 PRESTON ROAD, STE 515 CITY: DALLAS STATE: TX ZIP: 75240 SC 13D/A 1 sc13da.txt AMENDMENT NO. 4 TO SCHEDULE 13D 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 4 SAFEGUARD HEALTH ENTERPRISES, INC. (Name of Issuer) COMMON STOCK, $.01 PAR VALUE (Title of Class of Securities) 786444109 (CUSIP Number) DAVID K. MEYERCORD, ESQ. STRASBURGER & PRICE, L.L.P. 901 MAIN STREET, SUITE 4300 DALLAS, TEXAS 75202 (214) 651-4300 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) JULY 24, 2000 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 SCHEDULE 13D CUSIP NO. 786444109 -------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON JACK R. ANDERSON - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 3,067,615 ---------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 100,000 ---------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 3,067,615 ---------------------------------------------- PERSON 10 SHARED DISPOSITIVE POWER WITH: 100,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,167,615 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.1% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- Page 2 of 7 3 ITEM 1. SECURITY AND ISSUER. Common Stock, $.01 par value. SafeGuard Health Enterprises, Inc. 95 Enterprise Aliso Viejo, California 92656 ITEM 2. IDENTITY AND BACKGROUND. This amendment is filed by Jack R. Anderson. On March 1, 2000, SafeGuard Health Enterprises, Inc. (the "Issuer") entered into a Term Sheet Agreement, dated March 1, 2000 (the "Term Sheet Agreement") with CAI Partners & Company II, Limited Partnership ("Partners"), CAI Capital Partners & Company II, Limited Partnership ("Capital Partners"), Jack R. Anderson ("Mr. Anderson"), Silicon Valley Bank ("Bank"), John Hancock Mutual Life Insurance Company and the other holders of the 7.91% Senior Notes of the Issuer due September 30, 2005 (collectively, "Hancock"), and Steven J. Baileys, D.D.S. ("Baileys") (Partners, Capital Partners, CAI Capital Partners & Company II-C, Limited Partnership, an affiliate of Partners and Capital Partners which has acquired certain rights of Partners and Capital Partners under the Agreement by an assignment ("CP II-C"), Mr. Anderson and Baileys being collectively referred to herein as the "Investors") relating to the lending of funds by the Investors to the Issuer and the subsequent conversion of such loans and other loans to the Company into Convertible Preferred Stock and Convertible Notes of the Issuer. On July 24, 2000, Bank agreed to sell the indebtedness of the Issuer owed to Bank subject to the terms of the Term Sheet Agreement, to the Investors and certain other parties pursuant to a Loan Document Purchase and Assignment Agreement dated June 30, 2000 (the "Agreement"). This amendment is filed because of the voting securities of the Issuer that Mr. Anderson has a right to acquire pursuant to the Agreement as set forth below in this report. (a) Name of Reporting Person -- Jack R. Anderson (b) Business Address -- 16475 Dallas Parkway, Suite 735 Addison, Texas 77001 (c) Principal occupation -- Private investor (d) Criminal Convictions -- none (e) Injunctions with respect to federal or state securities laws -- none (f) Citizenship -- U.S.A. Page 3 of 7 4 ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. This amendment is filed because of the execution of the Agreement described in Item 2 above and covers shares of Common Stock of the Issuer issuable upon the full conversion of all loans, preferred stock and notes to be acquired pursuant to the Agreement by Mr. Anderson. The shares of Common Stock reflected on this amendment as beneficially owned by Jack R. Anderson were acquired with personal funds. ITEM 4. PURPOSE OF TRANSACTION. On July 24, 2000, Bank entered into the Agreement dated June 30, 2000, with Partners, Capital Partners, CP II-C, Mr. Anderson, a trust controlled by Baileys and others. The purpose of the transaction is a purchase of the indebtedness owed to Bank by the Issuer, subject to the terms of the Term Sheet Agreement by the Investors and others. (a) Mr. Anderson does not have any plans or proposals to acquire any additional securities of the Issuer or to dispose of any securities of the Issuer. (b) Mr. Anderson does not have any plans or proposals involving any extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries. (c) Mr. Anderson does not have any plans or proposals involving the sale or transfer of a material amount of the assets of the Issuer and of its subsidiaries. (d) The board of directors of the Issuer presently consists of six members. Pursuant to the Agreement, at the closing, the board of directors of the Issuer is to consist of seven members, of which four will be individuals designated by the owners of the Investor Senior Loan (as defined in the Term Sheet Agreement), the Series A Preferred Stock and Series A Convertible Notes, as applicable. In addition, Mr. Anderson is currently on the Board of Directors of the Issuer. (e) Mr. Anderson has no plans or proposals to make any material change in the present capitalization of the Issuer or dividend policy of the Issuer. (f) Mr. Anderson does not have any plans or proposals to make any other material change in the Issuer's business or corporate structure. (g) Mr. Anderson does not have any plans or proposals to make any changes in the Issuer's charter, bylaws or instruments corresponding thereto which may impede the acquisition of control of the Issuer by any person. (h) Mr. Anderson does not have any plans or proposals to cause a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association. Page 4 of 7 5 (i) Mr. Anderson does not have any plans or proposals to cause any class of equity securities of the Issuer to become eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Act of 1934. (j) Mr. Anderson does not have any plans or proposals to take any action similar to any of the items discussed above. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. This amendment covers shares of Common Stock of the Issuer issuable upon the full conversion of all loans, preferred stock and notes to be acquired pursuant to the Agreement by Mr. Anderson. As of April 30, 2000, the Issuer had 4,747,498 shares of common stock outstanding. In the transactions contemplated by the Agreement, assuming full conversion of the Investor Senior Loan and Series A, B, and D Convertible Notes, the Series A, B, C and D Preferred Stock to be issued will collectively be convertible into 30,000,000 shares of Common Stock of the Issuer. As a result, after the purchase transaction and assuming the conversion of all such preferred stock to be issued in the purchase transaction, there will be 34,747,498 shares of Common Stock outstanding (based on the number of shares of common stock of the Issuer outstanding as of April 30, 2000). Mr. Anderson currently beneficially owns 283,000 shares of common stock of the Issuer of which (a) 183,000 shares are owned directly by Mr. Anderson of which he has sole voting and dispositive power and (b) 100,000 shares owned by his spouse as separate property as to which Mr. Anderson disclaims beneficial ownership but which are reflected in this report as beneficially owned with shared voting and dispositive power. The 283,000 shares shown as currently beneficially owned by Mr. Anderson represent approximately 5.96% of the currently issued and outstanding shares of common stock of the Issuer. After the consummation of the transactions contemplated by the Term Sheet Agreement and Agreement and assuming full conversion of all loans, preferred stock and notes, Mr. Anderson will own an additional 2,884,615 shares of Common Stock of the Issuer. These 2,884,615 shares, along with the 283,000 shares already beneficially owned by Mr. Anderson, would aggregate to 3,167,615 shares of Common Stock, which would represent approximately 9.1% of the shares of Common Stock of the Issuer outstanding after full conversion of all the loans, preferred stock and notes described in the Term Sheet Agreement and Agreement. Mr. Anderson has not effected any transaction involving shares of common stock of the Issuer at any time since more than 60 days prior to the date of this report. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. There are no contracts, agreements, understandings or relationships among the persons named in Item 2 or between such persons and any person with respect to any securities of the Issuer, except for a Shareholders' Agreement to be executed by the Investors, Bank, Hancock and the Issuer upon consummation of the transactions contemplated by the Term Sheet Agreement and Agreement. The Shareholders' Page 5 of 7 6 Agreement relates to a voting agreement consistent with the terms of the Term Sheet Agreement and certain drag-along rights for Partners, Capital Partners, CP II-C and Mr. Anderson. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. The following documents are filed as an exhibit to this report: 1. Term Sheet Agreement dated March 1, 2000, by and among the Issuer, the Investors, Bank and Hancock. 2. Loan Document Purchase and Assignment Agreement dated as of June 30, 2000, among Bank, the Investors and Others. Page 6 of 7 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date July 24, 2000 /s/ Jack R. Anderson ----------------------- ----------------------------------- Signature Jack R. Anderson ----------------------------------- Name/Title Page 7 of 7 8 EXHIBIT INDEX
EXHIBIT NUMBER DESCRIPTION - ------- ----------- 1. Term Sheet Agreement dated March 1, 2000, by and among the Issuer, the Investors, Bank and Hancock. 2. Loan Document Purchase and Assignment Agreement dated as of June 30, 2000, among Bank, the Investors and Others.
EX-1 2 ex1.txt TERM SHEET AGREEMENT DATED MARCH 1, 2000 1 EXHIBIT 1 SAFEGUARD HEALTH ENTERPRISES, INC. ---------- TERM SHEET AGREEMENT ---------- DATE: March 1, 2000 (the "Effective Date") PARTIES: 3. SafeGuard Health Enterprises, Inc. (the "Company") 4. CAI Partners and Company II, L.P. and CAI Capital Partners and Company II, L.P. (collectively "CAI") 5. Jack R. Anderson ("Anderson") 6. Silicon Valley Bank ("Bank") 7. John Hancock Mutual Life Insurance Company and the other holders of the 7.91% Senior Notes of the Company due September 30, 2005 (collectively "Hancock") 8. Steven J. Baileys, D.D.S. ("Baileys") ---------- This Term Sheet Agreement (the "Agreement") summarizes various binding agreements between the parties. It is not a letter of intent. The parties contemplate that the agreements evidenced by this Agreement will be memorialized in further documentation which may include a Shareholders Agreement, to be prepared and executed by the parties at a later date. However, the agreements evidenced by this Agreement are not subject to or conditioned upon the execution and delivery of such further documentation. 1. Investor Senior Loan. On the Effective Date hereof, CAI, Anderson, and Baileys (collectively the "Investors"), severally and not jointly, shall loan the Company the aggregate amount of $8,000,000 (the "Investor Senior Loan") in the following amounts: CAI -- $5,000,000; Anderson -- $2,500,000; and Baileys - -- $500,000. The Investor Senior Loan shall bear interest at the rate of ten percent (10%) per annum. Interest is payable quarterly and at maturity. The maturity date of the Investor Senior Loan is April 30, 2001. The maturity date of the Investor Senior Loan shall be accelerated in the event of a liquidation or dissolution of the Company. The Investor Senior Loan is unsecured but the Company agrees with the Investors to comply with the same negative pledges with respect to liens on its assets as is contained in the Loan Documents between the Company and the Bank and the Note Purchase Agreement between the Company and Hancock. The Company shall not incur any other indebtedness senior or equal to the Investor Senior Loan. Repayment of the Investor Senior Loan in full shall be prior to repayment of the Bank Loan and the Hancock Notes according to the subordination agreement set forth below. In the event of the closing of the sale of the Preferred Stock and Convertible Notes described below, the principal balance of the Investor Senior Loan shall be cancelled as consideration for the purchase of the Series A Preferred Stock and Series A Convertible Notes by the Investors. 2 2. Sale of Series A Preferred Stock and Series A Convertible Notes to the Investors. The Investors, severally and not jointly, agree to purchase from the Company (a) 64,000 shares of Series A Preferred Stock for an aggregate purchase price of $6.4 million and (b) Series A Convertible Notes having an aggregate principal amount of $1.6 million. The consideration for the Series A Preferred Stock and the Series A Convertible Notes shall be cancellation of the outstanding principal balance of the Investor Senior Loan. Accrued interest due under the Investor Senior Loan shall be payable in cash to the Investors on the date of closing. a. Series A Preferred Stock. The Series A Preferred Stock shall have the following rights, preferences and limitations: i. The Series A Preferred Stock shall have a liquidation preference of $100 per share or an aggregate liquidation preference of $6.4 million. The liquidation preference shall be senior to all other securities of the Company including the Series B, C and D Preferred Stock described below and the Common Stock. ii. The Series A Preferred Stock shall not have specified dividends but shall be entitled to participate on an as-converted basis in any dividends paid on the Common Stock of the Company or the Series B, C or D Preferred Stock. iii. The Series A Preferred Stock shall not be subject to mandatory redemption at the election of the Investors but shall be subject to redemption at a redemption price of $100 per share by the Company at any time on or after ten (10) years after the original date of issuance. iv. The Series A Preferred Stock shall be convertible into shares of Common Stock at a conversion price of $1.00 per share. Each share of Series A Preferred Stock shall be initially convertible into 100 shares of Common Stock based on the $100 liquidation preferential amount thereof. The conversion price and number of shares will be subject to customary anti-dilution adjustments for stock splits, share dividends, recapitalizations, stock issuances, etc., with the anti-dilution adjustment for the issuance of shares at less than the conversion price being determined on the "weighted average method." v. Subject to the provisions of Section 3A hereof, the Series A Preferred Stock, voting as a single class, shall be entitled to elect a majority (4) of the Board of Directors. On all other matters, the holders of the Series A Preferred Stock shall vote together with the holders of the Common Stock and the Series B, C and D Preferred Stock and shall be entitled to cast one vote for each share of Common Stock into which the Series A Preferred Stock is convertible. vi. The approval of the Series A Preferred Stock, voting as a separate class, shall be required for the issuance of any securities having liquidation or other rights senior or superior or equal in any respect to the rights of the Series A Preferred Stock. 3 b. Series A Convertible Notes. The Series A Convertible Notes shall have the following terms. i. The Series A Convertible Notes shall bear interest at the rate of ten percent (10%) per annum from the date of issuance, payable quarterly and at maturity. ii. The Series A Convertible Notes shall be automatically converted into shares of Series A Preferred Stock upon the approval by the stockholders of the Company of an amendment to its certificate of incorporation increasing the number of authorized shares of Common Stock sufficient for the issuance of Common Stock upon the conversion of the shares of Series A Preferred Stock and the Series B, C and D Preferred Stock issuable upon the automatic conversion of the Series A Convertible Notes and the Series B, C and D Convertible Notes. The conversion price will be $100 per share and subject to the same anti-dilution protection as the Series A Preferred Stock. Initially the Series A Convertible Note will be convertible into an aggregate of 16,000 shares of Series A Preferred Stock. iii. The Series A Convertible Notes shall have no voting rights. iv. The Series A Convertible Notes and the payment thereof shall be senior and superior to the Series B, C and D Convertible Notes. 3. Sale of Series B, C and D Preferred Stock and Series B, C and D Convertible Notes. The Bank and Hancock agree to purchase an aggregate of 176,000 shares of Series B, C and D Preferred Stock and Series B, C and D Convertible Notes having an aggregate principal balance of $4.4 million. The consideration for the Series B Preferred Stock and Series B Convertible Notes shall be the cancellation of all indebtedness and obligations of any kind of the Company, whether principal, interest, costs, expenses or other, to the Bank and Hancock, respectively. The amount of shares of Series B, C and D Preferred Stock and principal amount of the Series B, C and D Convertible Notes shall be allocated to the Bank and Hancock, respectively, as follows: (i) the Bank and Hancock shall each purchase 32,000 shares of Series B Preferred Stock (in the aggregate 64,000 shares) and a Series B Convertible Note with a principal balance of $.8 million (in the aggregate $1.6 million); (ii) the Bank shall purchase 24,000 shares of Series C Preferred Stock and a Series C Convertible Note with the principal balance of $.6 million, and (iii) Hancock shall purchase 88,000 shares of Series D Preferred Stock and a Series D Convertible Note with the principal balance of $2.2 million. a. Series B, C and D Preferred Stock. The rights, preferences and limitations of the Series B, C and D Preferred Stock shall be identical except as set forth below: i. The Series B, C and D shall have a liquidation preference of $100 per share. The Series B Preferred Stock liquidation preference shall be senior to the Series C Preferred Stock liquidation preference. The Series C Preferred Stock liquidation preference shall be senior to the Series D Preferred Stock liquidation preference. The Series B, C and D Preferred Stock liquidation preferences shall be secondary to the Series A Preferred Stock but prior to any liquidation rights of the Common Stock. 4 ii. The Series B, C and D Preferred Stock shall not have specified dividends but shall be entitled to participate on an as-converted basis in any dividends paid on the Common Stock of the Company or the Series A, B, C or D Preferred Stock as the case may be. iii. The Series B, C and D Preferred Stock shall not be subject to mandatory redemption at the election of the Investors but shall be subject to redemption at a redemption price of $100 per share by the Company at any time on or after ten (10) years after the original date of issuance. iv. The Series B, C and D Preferred Stock shall be convertible into shares of Common Stock at a conversion price of $1.00 per share. Each share of Series B, C and D Preferred Stock shall be initially convertible into 100 shares of Common Stock based on the $100 liquidation preferential amount thereof. The conversion price and number of shares will be subject to customary anti-dilution adjustments for stock splits, share dividends, recapitalizations, stock issuances, etc., with the anti-dilution adjustment for the issuance of shares at less than the conversion price being determined on the "weighted average method." v. Subject to the provisions of Section 3A hereof, the Series B, C and D Preferred Stock voting together as a single class, shall be entitled to elect one director to the Board of Directors. On all other matters, the holders of the Series B, C and D Preferred Stock shall vote together with the holders of the Series A Preferred Stock and the Common Stock and shall be entitled to cast one vote for each share of Common Stock into which the Series B, C and D Preferred Stock is convertible. vi. The approval of the Series B, C and D Preferred Stock, voting as a separate class, shall be required for the issuance of any security of the Company having liquidation or other rights senior and superior or equal in any respect to the rights of the Series B, C and D Preferred Stock. b. Series B, C and D Convertible Notes. The terms of the Series B, C and D Convertible Notes shall be identical to the Series A Convertible Notes except that (i) the Series B, C and D Convertible Notes shall be convertible into Series B, C and D Preferred Stock, respectively and (ii) payment of the Series B Convertible Note shall be senior and superior to the Series C Convertible Note, (iii) payment of the Series C Preferred Note shall be senior and superior to payment of the Series D Convertible Note. Initially the Series B, C and D Convertible Notes will be convertible into an aggregate of 16,000 shares of Series B Preferred Stock, 6,000 shares of Series C Preferred Stock and 22,000 shares of Series D Preferred Stock, respectively. 3A. Change in Class Vote Applicable to Elections. In the event that CAI and Anderson at any time sell fifty percent (50%) or more of their respective Investor Senior Loan or their respective Series A Preferred Stock and Series A Convertible Notes, then, with respect to the election of directors, the Series A, B, C and D Preferred Stock shall be entitled to vote together as a single class to elect five (5) directors to the Board of Directors and the provisions of Section 2.a.v. and Section 3.a.v. hereof with respect to the election of directors shall not be applicable. 4. Closing. The closing of the sale of the Preferred Stock and the Convertible Notes shall occur on the first calendar day of the calendar month following the month in which satisfaction of the following conditions occurs effective immediately prior to the commencement of business on such day: 5 a. Regulatory Approval. Receipt of all required regulatory approvals to the transactions contemplated by this Agreement unless otherwise waived by CAI and Anderson; b. Performance. The performance by all of the Investors, the Bank and Hancock of their obligations to purchase the Preferred Stock and the Convertibles Notes as described above; c. Bankruptcy. The Company shall not have been placed in bankruptcy, either voluntary or involuntarily; d. Receivership. Neither the Company nor any of its subsidiaries shall have been placed in a receivership or conservatorship by any regulatory agency unless otherwise waived by CAI and Anderson; and e. Forbearance. The Banks and Hancock have complied with the forbearance and subordination agreements set forth in this agreement. The Closing shall not be subject to any other conditions precedent. 5. Terminated Purchase Agreement. The Company, the Bank and Hancock acknowledge and agree that CAI and Anderson properly terminated that certain Debenture and Note Purchase Agreement dated as of June 29, 1999 (the "Terminated Purchase Agreement") pursuant to Sections 8.4(a) and 8.4(b) thereof and waives and releases any contrary claim or assertion. This Agreement does not supersede or extinguish any of the rights of CAI and Anderson under the Terminated Purchase Agreement that survived the termination thereof including, without limitation, their rights to be reimbursed costs and expenses as provided therein. Such costs and expenses which shall not exceed $250,000 in the aggregate, together with the costs and expenses of CAI and Anderson in connection with this Agreement, shall be paid immediately after the execution of this Agreement out of the proceeds of the Investor Senior Loan. 6. Subordination Agreement. The Bank and Hancock agree that the Investor Senior Loan shall be paid 100% in full in cash before any payment of any kind shall be made on the Bank Loan or the Hancock Notes. Any distribution which would otherwise, but for the provision of this Agreement, be payable or deliverable in respect of the Bank Loan or the Hancock Notes shall be paid or delivered directly to the Investors in payment of the Investor Senior Loan until the Investor Senior Loan, principal and interest, is paid 100% in full. For the purpose thereof "distribution" means, with respect to any indebtedness (a) any payment or distribution by any person of cash, securities or other property, by set-off or otherwise, on account of such indebtedness or obligation, (b) any redemption, purchase or other acquisition of such indebtedness or obligation by any person or (c) the granting of any lien or security interest to or for the benefit of the holders of such indebtedness or obligation in or upon any property of any person. The Investor Senior Loan shall continue to be treated as debt that is senior to the Bank Loan and the Hancock Notes and the provisions of this Agreement shall continue to govern the relative rights and priorities of the Investors, the Bank and Hancock even if all or part of the Investor Senior Loan is subordinated, set aside, voided, invalidated or disallowed in connection with any proceeding or sale or transfer or other distribution of all or substantially all of the assets of the Company and this Agreement shall be reinstated if at any time any payment of the Investor Senior Loan is rescinded or must otherwise be returned by any holder of the Investor Senior Loan. The Bank and Hancock agree not to initiate or prosecute any claim, action, or other proceeding challenging the enforceability or validity of the Investor Senior Loan. 6 7. Forbearance Agreement. Until April 30, 2001, the Bank and Hancock shall not demand or accept any payment, principal or interest, or accelerate or take any enforcement action with respect to the Bank Loan and the Hancock Notes. For the purposes hereof "enforcement action" means any of the following: (a) to take from or for the account of the Company by set-off or in any other manner the whole or any part of any monies which may now or after be owing by the Company with respect to the Bank Loan or the Hancock Notes; (b) to sue for payment of, or initiate or participate in any other suit, action or proceeding against the Company (i) to enforce payment of or to collect the whole or any part of the Bank Loan or the Hancock Notes or (ii) to enforce any other rights, powers, privileges or remedies under the Bank Loan Documents or the Hancock Note Agreement; or (c) to take any action under the provisions of any state or federal law to enforce, foreclose upon, take possession of or sell any property or assets of the Company. In addition, the Bank and Hancock shall agree to cooperate to the extent commercially reasonable with respect to any other forbearance matters which shall be required in order for the Company to receive a "clean" audit report in its financial statements without any qualifications or exceptions. 8. Shareholders Agreement. The Investors, the Bank and Hancock agree to an agreement among such parties having the following provisions: a. Voting. Such parties agree to vote all shares of voting securities of the Company now or hereafter held by such parties (i) to approve an amendment to the certificate of incorporation of the Company increasing the authorized number of shares of Common Stock of the Company to a number sufficient to permit the conversion of the Series A Preferred Stock and the Series B Preferred Stock issuable upon conversion of the Convertible Notes as specified above, and (ii) to maintain the size of the Board of Directors at seven (7), and (iii) to take and authorize any such further actions as may be necessary or required to fully effectuate this Agreement. The holders of the Series A Preferred Stock shall elect as a director an individual designated by the Bank and Hancock and reasonably approved by the holders of the Series A Preferred Stock. Upon the closing, the director designated by the Bank and Hancock shall be elected to the Board of Directors to fill the vacant position as contemplated by Section 9(d) below. b. Drag-Along Rights. CAI and Anderson shall have drag-along rights with respect to the shares owned by the Bank and Hancock in connection with a sale of the Company in a transaction approved by the Board of Directors of the Company; provided that if the value of the securities of the Company in such sale is less than $30 million, a fairness opinion by an investment banker shall be provided. 9. Certain Representations. SafeGuard, acting by and through its duly authorized officers, and Baileys, individually, hereby represent and warrant to the Investors, the Bank and Hancock as follows: a. Material Events. To the best knowledge of the Company and Baileys, there is no event or claim of any kind whatsoever that has occurred, is pending or is threatened that has had or could have a material adverse effect on the Company or would be considered a material event as such term is defined under federal securities laws (including court decisions interpreting the same) which event or claim has not been publicly disclosed in a report filed by the Company with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, or otherwise publicly disclosed in a press release issued by the Company or that certain press release dated December 17, 1999 issued by Berman, Devalerio & Pease, L.L.P. related to a class action lawsuit against the Company. For the purpose hereof, any notice of termination or non-renewal, notice of intent to terminate or non-renew or termination 7 or non-renewal of any group or individual customer contracts which either individually or in the aggregate represent a material number of the members of the plan of the Company shall constitute a material adverse event. b. Regulatory Compliance. Up to $5 million of the proceeds of the Investor Senior Loan will be used immediately for a capital contribution to Safe Health Life Company, the insurance subsidiary of the Company, required to be made on the Effective Date by applicable governmental regulations. Except for such capital infusion, all the other subsidiaries of the Company are in compliance with all material provisions of the laws, rules and regulations applicable to the certificate of authority or license held by such subsidiary and none of the subsidiaries has any deficit in any required reserves, capital or other funds required to be maintained by such subsidiary under applicable regulatory requirements. c. Board Approval. This Agreement and the transactions provided in this Agreement, including, without limitation, the issuance of the Investor Senior Loan, the Preferred Stock, the Convertible Notes and the approval of the amendment to the certificate of incorporation as contemplated herein, have been approved by the affirmative vote of not less than seventy-five percent (75%) of the current members of the Board of Directors of the Company at a meeting duly called and held in accordance with the Bylaws of the Company. The Board of Directors have taken all action and adopted all approvals necessary in order that the transactions contemplated by this Agreement do not and shall not cause the rights issued to the stockholders of the Company pursuant to that certain Rights Agreement, dated as of March 22, 1996 between the Company and American Stock Transfer and Trust Company, as Rights Agent, to become exercisable or any similar rights under any other rights agreement applicable to the stockholders of the Company to become exercisable. d. Board of Directors. The following changes with respect to the Board of Directors of the Company have occurred or have been duly authorized and approved by the Board of Directors of the Company in accordance with the Bylaws of the Company: i. After the Board approvals described in Section 9(c) above, Messrs. Cox, McKenna, Mann, Stevens and Boyd resigned from the Board of Directors of the Company and the incumbent directors of the Company were then Baileys, Brendzel and Dennis Gates; ii. Jack R. Anderson, Leslie B. Daniels and James E. Buncher were then by the Board of Directors appointed as directors of the Company effective upon execution of this Agreement; and iii. One vacancy shall remain on the Board of Directors of the Company to be filled upon the closing by the holders of the Series B, C and D Preferred Stock as provided in Section 8(a)(iii) above. e. Employment Agreements. Messrs. Cox, Brendzel and Kaufman have agreed that any acceleration or vesting of any rights or benefits under his respective employment agreement with the Company or otherwise resulting from a change of control, including severance payments, shall not occur by virtue of the transactions contemplated by this Agreement and have waived any claim that such is the case. 8 10. Cancellation of Warrants. Upon the closing of the sale of the Preferred Stock and the Convertible Notes, Hancock agrees that those certain Warrants for an aggregate of 382,000 shares of Common Stock of the Company issued pursuant to that certain First Amendment and Waiver to Note Purchase Agreement dated as of May 28, 1999 shall be cancelled in all respects. 11. Registration Rights. None of the Investors, the Bank or Hancock shall have any demand registration rights. The Investors, the Bank and Hancock shall have piggyback registration rights with respect to any securities offering by the Company (other than in connection with an acquisition or an employee benefit plan) on a pro rata basis, subject to any underwriter's cutback on the total number of shares available to be sold by stockholders of the Company in the offering. The parties shall have indemnification rights in connection with any such offering as specified in the Registration Rights Agreement attached as an Exhibit to the Terminated Purchase Agreement. The Company will pay all registration expenses but no selling expenses. 12. Certain Covenants. a. Regulatory Filings. Each party hereto agrees to proceed in good faith and as soon as practicable to make and pursue all regulatory filings and to obtain of all regulatory approvals required for the transactions specified in this Agreement. b. Stockholder Meeting. Upon the closing of the sale of the Preferred Stock and the Convertible Notes, SafeGuard shall immediately take all actions required to call and hold a special meeting of the stockholders for the purposes of approving an amendment to the certificate of incorporation of the Company to increase the number of authorized shares of Common Stock of the Company as contemplated by this Agreement. 13. Other Understandings. a. Board of Directors. So long as the Investor Senior Loan is outstanding, three (3) directors of the Company shall be designees of CAI and Anderson. b. Senior Debt. Notwithstanding any provision of this Agreement to the contrary, the Board of Directors of the Company may borrow up to $3,500,000 for working capital purposes on a basis senior and superior to the Investor Senior Loan, the Bank Loan, the Hancock Notes, the Preferred Stock and the Convertible Notes without the consent of the Investors, the Bank or Hancock. c. Outstanding Shares. In connection with the transactions provided in this Agreement, the issued and outstanding shares of Common Stock of the Company on the Effective Date shall remain issued and outstanding and the stock options granted to employees and officers of the Company under the stock option plan of the Company prior to the Effective Date shall remain issued and outstanding in accordance with their terms. d. Costs and Expenses. Whether or not the transactions contemplated by this Agreement are consummated, the Company will pay (or reimburse upon request) all costs and expenses of CAI and Anderson including, without limitation, reasonable fees and expenses of their consultants, counsel and 9 accountants, in connection with or leading to the preparation, negotiation and execution of this Agreement and the consummation of the transactions contemplated by this Agreement. e. Indemnity. The Company will pay and indemnify the Investors, the Bank and Hancock and their respective stockholders, partners, trustees, officers, employees and agents, against all liability and loss with respect to (i) all claims for fees or commissions of brokerage or finders engaged by the Company with respect to the transactions contemplated by this Agreement, (ii) all taxes, fees and other public charges payable in connection with the issuance of any of the Preferred Stock or Convertible Notes or the execution, delivery, and enforcement of this Agreement for any of the rights of the Preferred Stock or Convertible Notes, and (iii) all claims and suits, either direct or derivative, commenced by or on behalf of the Company or the stockholders of the Company relating to or arising out of this Agreement or the transactions contemplated herein. Such rights shall survive the termination or consummation of this Agreement. The Company shall indemnify the three directors designated by CAI and Anderson to the fullest extent permitted by applicable law. f. Waiver. Baileys, the Bank and Hancock agree that they shall not assert, and hereby waive, any claims in their capacity as a shareholder or creditor of the Company against the three directors designated by CAI and Anderson for acts or omissions in their capacity as directors of the Company at any time during the period from the Effective Date through the closing date except for intentional acts of fraud or dishonesty. g. Employment Agreement. Baileys agrees that any acceleration or vesting of any rights or benefits under his employment agreement or otherwise resulting from a change of control, including severance payments, shall not occur by virtue of the occurrence of the transactions contemplated by this Agreement and waives any claim that such is the case. In addition, Baileys agrees to voluntarily resign his position as chief executive officer of the Company as of the Effective Date and the Company shall have no obligation to make any severance payments of any kind thereunder as a result thereof. Baileys shall remain as Chairman of the Board of Directors of the Company. All other provisions of his employment agreement shall remain in full force and effect. 14. Miscellaneous. a. Notices. All notices and other communications under this Agreement shall be in writing and shall be deemed given upon (i) confirmation or receipt of a facsimile transmission (ii) confirmed delivered by standard overnight carrier, (iii) when delivered by hand or (iv) the expiration of five (5) business days after the date when mailed by registered or certified mail (postage prepaid, return receipt requested), addressed to respective parties as set forth in the prior Purchase Agreement, the Bank Loan Documents or the Hancock Note Agreement, as applicable. b. Entire Agreement. This Agreement constitutes the entire agreement and supersedes all prior agreements and understandings (other than the provisions of the Terminated Purchase Agreement that survive termination thereof), both written or oral, among the parties or any of them, with respect to the subject matter hereof. c. Assignment. This Agreement shall not be assigned by operation in law or otherwise, except that (i) Anderson may assign part of his respective rights and obligations hereunder to up to two third 10 parties and (ii) CAI may assign all or any part of its respective rights and obligations hereunder to any affiliated investment partnership. d. Amendment. This Agreement may not be amended except by instrument in writing signed on behalf of each of the parties hereto. e. Binding Effect. This Agreement shall be binding upon the parties hereto, their respective heirs, representatives, successors and permitted assigns specifically including any transferees of the Bank Loan, the Hancock Notes, the Investor Senior Loan, the Preferred Stock and the Convertible Notes. f. Exculpation. Among Investors, Bank and Hancock. Each of the Investors, the Bank and Hancock acknowledges that such party is not relying upon any person, firm or corporation, other than the representations of the Company contained herein, in making its investment or decision to invest in the Investor Senior Loan, the Preferred Stock or the Convertible Notes and specifically each such party has not relied on any representation or warranty of any of such other parties in making such investment or decision. The Company acknowledges that it is not relying upon any representation or warranty of the Investors, the Bank and Hancock in entering into this Agreement. g. Arbitration. In the event of any dispute between any one or more or all of the parties to this Agreement with respect to the respective rights and obligations of the parties under this Agreement, such dispute shall be settled by arbitration in accordance with the arbitration procedures set forth in the Terminated Purchase Agreement. h. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without giving effect to the provisions thereof relating to conflicts of laws. i. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same agreement. (REMAINDER OF PAGE INTENTIONALLY LEFT BLANK) 11 IN WITNESS WHEREOF, the parties hereto have executed this Term Sheet Agreement as of the Effective Date. CAI PARTNERS AND COMPANY II, L.P. By: CAI PARTNERS G.P. AND COMPANY, L.P., GENERAL PARTNER By: /s/ Leslie B. Daniels ---------------------------------- Leslie B. Daniels CAI CAPITAL PARTNERS AND COMPANY II, L.P. By: CAI CAPITAL PARTNERS G.P. AND COMPANY, L.P., GENERAL PARTNER By: /s/ Leslie B. Daniels ---------------------------------- Leslie B. Daniels /s/ Jack R. Anderson - ------------------------------------------- Jack R. Anderson /s/ Steven J. Baileys - ------------------------------------------- Steven J. Baileys, D.D.S., Trustee SAFEGUARD HEALTH ENTERPRISES, INC. By: /s/ Steven J. Baileys ---------------------------------------- Steven J. Baileys, D.D.S., Chairman and Chief Executive Officer By: /s/ Ronald I. Brendzel ---------------------------------------- Ronald I. Brendzel, Secretary JOHN HANCOCK LIFE INSURANCE COMPANY f/k/a JOHN HANCOCK MUTUAL LIFE INSURANCE COMPANY By: /s/ Stephen J. Blewitt ---------------------------------------- Name: Stephen J. Blewitt -------------------------------------- Title: Authorized Signatory ------------------------------------- JOHN HANCOCK VARIABLE LIFE INSURANCE COMPANY By: /s/ Stephen J. Blewitt ---------------------------------------- Name: Stephen J. Blewitt -------------------------------------- Title: Authorized Signatory ------------------------------------- INVESTORS PARTNER LIFE INSURANCE COMPANY (f/k/a JOHN HANCOCK LIFE INSURANCE COMPANY OF AMERICA) By: /s/ Stephen J. Blewitt ---------------------------------------- Name: Stephen J. Blewitt -------------------------------------- Title: Authorized Signatory ------------------------------------- MELLON BANK, N.A., solely in its capacity as Trustee for Bell Atlantic Master Trust (f/k/a Nynex Master Pension Trust), (as directed by John Hancock Mutual Life Insurance Company) and not in its individual capacity By: /s/ Carole Bruno ---------------------------------------- Name: Carole Bruno -------------------------------------- Title: Authorized Signatory ------------------------------------- SILICON VALLEY BANK By: /s/ Nido Paras ---------------------------------------- Name: Nido Paras -------------------------------------- Title: Senior Vice President ------------------------------------- EX-2 3 ex2.txt LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT 1 EXHIBIT 2 LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT THIS LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT (the "Agreement") is made as of this 30th day of June, 2000 (the "Effective Date") by and between Silicon Valley Bank ("Assignor") and those certain other parties executing this Agreement as shown on the signature page hereto (collectively the "Assignees"). RECITALS A. Assignor is a party to certain loan documents which evidence certain loans by Assignor to SafeGuard Health Enterprises, Inc., a Delaware corporation ("Borrower"), which are listed on Exhibit "A" attached hereto and incorporated herein by this reference and collectively referred to herein as the "Loan Documents." Copies of the Loan Documents are attached hereto as Exhibit "A-1" and incorporated herein by this reference. B. Assignees and Assignor desire for Assignees to purchase all of Assignor's right, title, and interest in and to the Loan Documents and all the indebtedness of Borrower to Assignor evidenced thereby for an aggregate purchase price of $5,000,000 FIVE MILLION DOLLARS ($5,000,000). C. Assignor desires to transfer to Assignees all of Assignor's right, title, and interest in and to the Loan Documents and all the indebtedness of Borrower to Assignor evidenced thereby on the terms and conditions set forth herein. AGREEMENT NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 1. Payment of Purchase Price. At the Closing (hereinafter defined), the Assignees shall pay to Assignor the aggregate sum of $5,000,000 (FIVE MILLION DOLLARS) by wire transfer, cashier's check, or other readily available funds (the "Purchase Price"). The obligations of the Assignees shall be several and not joint under this Agreement. Each Assignee shall be only obligated to pay the respective portion of the aggregate $5,000,000 Purchase Price reflected under the respective signature of the Assignee on the signature page hereto. 2. Conditions to Obligations of the Assignor. The obligations of the Assignor hereunder shall be subject to and conditioned upon the receipt of the entire $5,000,000 Purchase Price by the Assignees collectively. The Assignor shall not be obligated to close the transaction contemplated by this Agreement unless the total aggregate Purchase Price is paid by the Assignees The obligations of the Assignor hereunder shall not be subject to or conditioned upon any other conditions precedent. 3. Conditions to Obligations of the Assignees. The obligations of the Assignees hereunder shall be subject to and conditioned upon the receipt of all required regulatory approvals necessary to consummate 2 the change of control of the Borrower resulting from the transactions contemplated by the Term Sheet Agreement (referenced as Item 1 on Exhibit A hereto) and contemplated by this Agreement which results in a change of the acquiring parties as such term is defined under the governmental regulations applicable to the change of control of Borrower. Other than receipt of such required regulatory approvals and the accuracy of the representations and warranties of the Assignor on the date of Closing, the obligations of the Assignees hereunder shall not be subject to or conditioned upon any other conditions precedent. 4. Closing. The closing (the "Closing") under this Agreement shall occur simultaneously with the closing of the sale of the Preferred Stock pursuant to the Term Sheet Agreement. 5. Assignment of Loan Documents. In consideration of the receipt of the Purchase Price, Assignor shall grant, assign, convey, transfer, and set over to Assignees (i) all of the Loan Documents, including, without limitation, the promissory notes included therein, (ii) all sums payable thereunder, and (iii) all of Assignor's rights, title and interest in the collateral securing the Loan as described in the Loan Documents and all rights to enforce any guaranties contained therein, together with all its rights, remedies and powers, benefits, fees and revenues pertaining thereto, with good right to collect, enforce, release and discharge the same, as well as any and all liens, security interests, assignments and financing statements existing and securing the obligation, in and under the Loan Documents thereunder, to have and hold each of the Loan Documents, together with all right, title, interest, liens, privileges, claims, demands and equities existing and to exist in connection thereunder or as security therefor unto Assignees, their respective successors and assigns. Simultaneously with the Closing under this Agreement and receipt of the Purchase Price by Assignor, Assignor shall endorse to Leslie B. Daniels as Agent for Assignees those Loan Documents consisting of negotiable promissory notes and Assignor shall deliver to Assignees the original Loan Documents. In addition, simultaneously with the Closing under this Agreement and receipt of the Purchase Price by Assignor, Assignor shall execute and deliver to Assignees such UCC financing statement change forms as may be reasonably requested by Assignees to reflect the assignment herein. Except as expressly set forth in Section 7 of this Agreement, the sale and assignment pursuant to this Agreement is made without recourse to Assignor and without any representation and warranty by Assignor. 6. Acceptance of Assignment. Effective as of the Closing hereunder, Assignees shall accept the assignment set forth in Section 5 of this Agreement. 7. Assignor's Representations. As of the Effective Date and as of the date of the Closing, Assignor represents, warrants, and covenants to Assignees that Exhibit A sets forth a true and complete list of all the agreements, documents, and instruments entered into in connection with the transactions contemplated by the Loan Documents; that the copies of the Loan Documents attached as Exhibit A-1 are true, accurate and complete copies of the originals of such documents; that the Loan Documents have not been amended, modified, supplemented or released except as reflected in copies of the Loan Documents attached as Exhibit A-1; that Assignor is the present legal and equitable owner and holder of each of the Loan Documents described herein, the indebtedness evidenced thereby, and all pledges, liens and security interests existing in connection therewith and securing payments thereof; that Assignor has the full right and authority to transfer and convey each of the Loan Documents described herein, the indebtedness evidenced thereby and all security therefor, and to execute this Agreement; that the Assignor has not assigned, mortgaged, hypothecated, granted a security interest in, or otherwise encumbered, any of the Loan Documents, the indebtedness evidenced thereby or any of said liens or security to any other parties; that, as of the Effective Date $7,044,824.68 is the outstanding principal amount of the Loan Documents; that, as -2- 3 of June 15, 2000, interest due under the Loan Documents has been paid through December 31, 1999; that, to the best of Assignor's knowledge, no defense, counterclaim or right of setoff exists with respect to the indebtedness evidenced by the Loan Documents and that the Borrower has not asserted to Assignor that any exist; that Assignor has not subordinated the indebtedness represented by the Loan Documents to any other indebtedness of Borrower; that, to the Assignor's knowledge, the liens evidenced by the Loan Documents are valid against the collateral described therein; and that Assignor has not released any of its rights of security for payment of any indebtedness evidenced by the Loan Documents. Assignor expressly waives and releases any and all rights that Assignor may now have or hereafter have to establish or enforce any lien or security interest existing under any of the Loan Documents as security for the payment of any other or future indebtedness of Borrower to Assignor. Assignor further represents, warrants and covenants that, in the event it receives any payments from Borrower on the indebtedness evidenced by the Loan Documents from and after the Effective Date, Assignor shall remit all such payments to Leslie B. Daniels as Agent for Assignees on the date of Closing and, in the event it receives any such payments after the date of the Closing, Assignor shall promptly remit all such payments to Leslie B. Daniels as Agent for the Assignees. 8. Assignees' Representations. Assignees jointly and severally represent, warrant and covenant to Assignor the following: (a) Except with respect to a breach of the representations and warranties specifically made by Assignor in Section 7 of this Agreement or an action for specific performance if Assignor improperly fails or refuses to consummate the Closing under this Agreement, that, to the extent Assignees have or may have any claims, rights or recourse against Assignor relating to the indebtedness of the Borrower, or this Agreement, Assignees fully release Assignor from and against any and all such liability, intend this Agreement to be a full and final accord and satisfaction of any such claims, rights, or recourse, known or unknown, and acknowledge that they are familiar with Section 1542 of the California Civil Code, and hereby waive and relinquish any right or benefit they have or may have under Section 1542 of the California Civil Code, which provides: A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor. (b) That Assignees have conducted their own investigation and analysis of the Borrower and the Loan Documents and are not relying on any representations or warranties of Assignor, except for those representations and warranties specifically made by Assignor in Section 7 of this Agreement. (c) If Assignor must disgorge the payment of the Purchase Price, or any portion thereof, Assignor receives from Assignees, Assignees shall immediately reconvey, assign and transfer to Assignor all right, title and interest in the Loan Documents, or the respective portion thereof, and take all further necessary actions to ensure and protect the rights of Assignor. If Assignor must disgorge any amounts received from Borrower prior to the Closing, Assignees shall assign to Assignor such rights in the Loan Documents as Assignor reasonably requests to enforce the Loan Documents with respect to such disgorged amount. -3- 4 9. Further Assurances. Assignor and Assignees shall at their own cost and expense execute, acknowledge, file, and record such further documents and instruments and shall take such other actions as may be reasonably required or appropriate to carry out the intent and purposes of this Agreement. 10. Attorneys' Fees. Should any party hereto reasonably retain counsel for the purposes of enforcing or preventing the breach of any provision hereof, including, but not limited to, the instituting of any action or proceeding to enforce any provision hereof, for damages for reason of any alleged breach of any provision hereof, for declaration of such party's rights or obligations hereunder, or for any other judicial or equitable remedy, then, if said matter is settled by judicial determination (which term includes arbitration), the prevailing party, whether at trial or on appeal, shall be entitled to reimbursement by the losing party to the prevailing party for all costs and expenses incurred thereby, including, but not limited to reasonable attorneys', accountants' and appraisers' fees. 11. Binding on Heirs and Successors. This Agreement shall be binding on and shall inure to the benefit of the heirs, executors, administrators, successors and assigns of the parties hereto. 12. Entire Agreement, Modification, Waiver. This Agreement contains the entire agreement of the parties and supersedes any prior agreements or understandings, whether written or oral, relating to the subject matter hereof. Any oral representations, supplements or modifications concerning this Agreement shall be of no force or effect unless contained in a subsequent written modification signed by the party to be charged. No waiver of any of the provisions of this Agreement shall be deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. No delay or failure to assert rights hereunder shall be deemed, or shall constitute, a waiver of such rights. No waiver shall be binding unless executed in writing by the party making the waiver. 13. Governing Law and Venue. This Agreement shall be governed by the laws of the State of California without regard to its principles of conflicts of law. The parties hereto each submit to the exclusive jurisdiction of the state and federal courts in Santa Clara County, California for the purposes of any legal actions between Assignor and Assignees arising out of this Agreement. 14. Captions. The captions and section headings used herein are for convenience and for ease of reference only and constitute no part of this Agreement or understanding between the parties hereto, and no reference shall be made thereto for the purpose of construing or interpreting any of the provisions hereof. 15. Survival of Warranties. The warranties and representations, and covenants of the parties hereunder shall survive the transactions contemplated herein. 16. Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 17. Parties in Interest. Nothing in this Agreement, whether express or implied, is intended to confer any rights or remedies under or by reason of this Agreement on any persons other than the parties hereto and their respective successors and assigns, nor is anything in this Agreement intended to relieve or discharge the obligation or liability of any third persons to any party to this Agreement, nor shall any provision give any third persons any right of subrogation or action over or against any party to this Agreement. -4- 5 18. Singular, Plural, etc. Whenever the singular number is used herein and when required by the context, the same shall include the plural, and the masculine gender shall include the feminine and neuter genders, and the word "person" shall include corporation, firm, partnership, joint venture, trust, estate, or other association. 19. Invalidity. In the event that any condition, covenant, promise, or other provision herein contained is held to be invalid or void by any court of competent jurisdiction, the same shall be deemed severable from the remainder of this Agreement and shall in no way affect any other covenant, promise, condition, or other provision herein contained. If such condition, covenant, promise, or other provision shall be deemed invalid due to its scope or breadth, such provision shall be deemed valid to the extent of the scope or breadth permitted by law. 20. Exhibits. All Exhibits referred to herein are hereby attached hereto and incorporated herein by this reference with the same force and effect as if fully set forth herein. 21. Agency. Nothing contained in this Agreement shall be deemed or construed by the parties hereto or by any third person to create the relationship of principal and agent or of partnership or of joint venture or of any other association. Each of the parties hereto expressly disclaims any intention to create a partnership, joint venture, or principal-agent relationship. 22. Execution. This Agreement shall be executed in duplicate original. Transmittal of fully-executed signature pages to the other party by facsimile shall be deemed to constitute execution, provided original signature pages are simultaneously transmitted to that party by overnight mail. 23. Waiver of Jury Trial. THE PARTIES HERETO EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CLAIMS BASED ON CONTRACT, TORT, BREACH OF DUTY AND ANY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR BOTH PARTIES TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL. IN WITNESS WHEREOF, the parties have executed this Agreement as set forth below. ASSIGNOR: SILICON VALLEY BANK By /s/ Nido L. Paras --------------------------------- Name: Nido L. Paras Title: Senior Vice President ASSIGNEES: CAI PARTNERS AND COMPANY II, L.P. By: CAI PARTNERS G.P. AND COMPANY, L.P., GENERAL PARTNER -5- 6 By: /s/ Leslie B. Daniels --------------------------- Leslie B. Daniels $886,296 CAI CAPITAL PARTNERS AND COMPANY II, L.P. By: CAI CAPITAL PARTNERS G.P. AND COMPANY, L.P., GENERAL PARTNER By: /s/ Leslie B. Daniels ---------------------------- Leslie B. Daniels $1,800,551 CAI CAPITAL PARTNERS AND COMPANY II-C, L.P. By: /s/ Manfred W. Yu -------------------------------- Its: Assistant Secretary ------------------------------- $221,486 THE BAILEYS FAMILY TRUST By: /s/ Steven J. Baileys -------------------------------- Steven J. Baileys, D.D.S., Trustee $290,833 /s/ Jack R. Anderson ----------------------------------- Jack R. Anderson $919,389 The Burton Partnership, Limited Partnership By: /s/ Donald W. Burton -------------------------------- Donald W. Burton, General Partner $534,778 /s/ James E. Buncher ----------------------------------- James E. Buncher $173,333 -6- 7 /s/ Ronald I. Brendzel ----------------------------------- Ronald I. Brendzel $86,667 /s/ Dennis L. Gates ----------------------------------- Dennis L. Gates $86,667 The Borrower hereby consents to the transactions contemplated herein, acknowledges that, effective as of the date of the Closing, the Loan Documents, including, without limitation, all sums payable thereunder shall have been acquired by Assignees and acknowledges that future payments thereafter should be sent to Leslie B. Daniels, 767 Fifth Avenue, 5th Floor, New York, New York 10153, as Agent for Assignees. BORROWER: SAFEGUARD HEALTH ENTERPRISES, INC., a Delaware corporation By: /s/ James E. Buncher -------------------------------- Name: James E. Buncher Title: President -7- 8 EXHIBIT A LIST OF LOAN DOCUMENTS 1. Term Sheet Agreement dated March 1, 2000, among SafeGuard Health Enterprises, Inc., CAI Partners and Company II, L.P., CAI Capital Partners and Company II, L.P., Jack R. Anderson, Steven J. Baileys, Silicon Valley Bank and the holders of 7.91% Senior Notes of SafeGuard Health Enterprises due September 30, 2005. 2. $500,000 Straight Note, dated May 24, 1999, payable to SafeGuard Health Enterprises, Inc. by Anaheim Place Partners, L.P. with Allonge, dated June 21, 1999, payable to the order of Silicon Valley Bank, as Collateral Agent 3. Amended and Restated Loan and Security Agreement, dated May 27, 1999, between Silicon Valley Bank, Lender, and SafeGuard Health Enterprises, Inc., Borrower 4. Deed of Trust, Absolute Assignment of Leases and Rents, Security Agreement, Fixture Filing and Subordination Agreement, dated May 28, 1999, among SafeGuard Health Enterprises, Inc., Trustor, Chicago Title Company, Trustee and Silicon Valley Bank, Collateral Agent 5. Negative Pledge Agreement, dated May 28, 1999, between SafeGuard Health Enterprises, Inc., Borrower, and Silicon Valley Bank, Lender 6. Pledge Agreement, dated May 28, 1999, by SafeGuard Health Enterprises, Inc., Pledgor, and Silicon Valley Bank, Pledgee 7. Collateral Agency and Intercreditor Agreement, dated May 28, 1999, among SafeGuard Health Enterprises, Inc., Silicon Valley Bank, as Collateral Agent, and the Senior Noteholders 8. Collateral Assignment of Deed of Trust, dated June 22, 1999, from SafeGuard Health Enterprises, Inc., Assignor, to Silicon Valley Bank as Collateral Agent, Assignee 9. $200,000 Credit Note and Security Interest, dated September 12, 1997, payable to SafeGuard Health Enterprises, Inc., by Associated Dental Services, Inc. 10. $300,000 Credit Note and Security Interest, dated October 13, 1997, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 11. $150,000 Credit Note and Security Interest, dated November 14, 1997, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 12. $200,000 Credit Note and Security Interest, dated December 10, 1997, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. -8- 9 13. $150,000 Credit Note and Security Interest, dated January 13, 1998, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 14. $50,000 Credit Note and Security Interest, dated March 16, 1998, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 15. $200,000 Credit Note and Security Interest, dated April 29, 1998, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 16. $150,000 Credit Note and Security Interest, dated June 16, 1998, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 17. $50,000 Credit Note and Security Interest, dated July 23, 1998, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 18. $150,000 Credit Note and Security Interest, dated August 12, 1998, payable to SafeGuard Health Enterprises, Inc. by Associated Dental Services, Inc. 19. Opinion Letter, dated May 28, 1999, to Silicon Valley Bank from Ronald I. Brendzel, Senior Vice President and General Counsel of SafeGuard Health Enterprises, Inc., regarding First Waiver, Pledge, Intercreditor Agreement and Warrant 20. UCC-1, Financing Statement #9915960576 filed June 4, 1999, with California Secretary of State between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, as Collateral Agent, Secured Party 21. UCC-1, Financing Statement #9805560634 filed February 18, 1998, with California Secretary of State between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party 22. UCC-1, Financing Statement #033613 filed February 18, 1998, with Texas Secretary of State between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party 23. UCC-1, Financing Statement #2152 filed February 24, 1998, with St. Louis County, Missouri Recorder of Deeds, between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party 24. UCC-1, Financing Statement #2880806 filed February 18, 1998, with Missouri Secretary of State, between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party. 25. UCC-1, Financing Statement #01004984 filed February 18, 1998, with Arizona Secretary of State between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party 26. UCC-1, Financing Statement #980000036413 filed February 18, 1998, with Florida Secretary of State between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party -9- 10 27. UCC-1, Financing Statement #19982011158 filed February 18, 1998, with Colorado Secretary of State between SafeGuard Health Enterprises, Inc., Debtor, and Silicon Valley Bank, Secured Party -10- -----END PRIVACY-ENHANCED MESSAGE-----